This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO, Leprosy Fact Sheet 101, January 2003.
2. Meyers WM, Gormus BJ, Walsh GP. Nonhuman sources of leprosy. Int J Lepr. 1992; 60:477–481.
3. Park JY, Cho SN, Youn JK, et al. Detection of antibodies to human nerve antigens in sera from leprosy patients by ELISA. Clin Exp Immunol. 1992; 87:368–372.
4. Khanolkar-Young S, Rayment N, Brickell PM, et al. Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol. 1995; 99:196–202.
5. Dana MR, Hochman MA, Viana MA, Hill CH, Sugar J. Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Arch Ophthalmol. 1994; 112:626–269.
6. Bertolli J, Pangi C, Frerichs R, Halloran ME. A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. Int J Epidemiol. 1997; 26:888–896.
Randomised conrolled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for the prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996; 348:17–24.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Stechenberg, B. (2008). Mycobacterium leprosy . In: The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Infectious Disease™. Humana Press. https://doi.org/10.1007/978-1-59745-391-2_25
Download citation
DOI: https://doi.org/10.1007/978-1-59745-391-2_25
Publisher Name: Humana Press
Print ISBN: 978-1-58829-967-3
Online ISBN: 978-1-59745-391-2
eBook Packages: MedicineMedicine (R0)